סילריל 1 ישראל - עברית - Ministry of Health

סילריל 1

unipharm ltd, israel - cilazapril - טבליה - cilazapril 1 mg - cilazapril - cilazapril - a blood pressure lowering agent.chronic heart failure.

טורבה 10 ישראל - עברית - Ministry of Health

טורבה 10

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 20 ישראל - עברית - Ministry of Health

טורבה 20

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 20 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 40 ישראל - עברית - Ministry of Health

טורבה 40

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 40 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

מרוניל 25 ישראל - עברית - Ministry of Health

מרוניל 25

unipharm ltd, israel - clomipramine hydrochloride - טבליה - clomipramine hydrochloride 25 mg - non selective monoamine reuptake inhibitors - depression of varying origin.in children and adolescents there is not sufficient evidence of safety and efficacy of maronil in the treatment of depressive states of varying aetiology and symptomatology. the use of maronil in children and adolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes.no experience is available in children younger than 5 years of age.

אזקור ישראל - עברית - Ministry of Health

אזקור

unipharm ltd, israel - ezetimibe - טבליה - ezetimibe 10 mg - ezetimibe

אטומיק 25 ישראל - עברית - Ministry of Health

אטומיק 25

unipharm ltd, israel - atomoxetine as hydrochloride - טבליות מצופות - atomoxetine as hydrochloride 25 mg - atomoxetine

אטומיק 40 ישראל - עברית - Ministry of Health

אטומיק 40

unipharm ltd, israel - atomoxetine as hydrochloride - טבליות מצופות - atomoxetine as hydrochloride 40 mg - atomoxetine

אטומיק 60 ישראל - עברית - Ministry of Health

אטומיק 60

unipharm ltd, israel - atomoxetine as hydrochloride - טבליות מצופות - atomoxetine as hydrochloride 60 mg - atomoxetine

אמלו 10 ישראל - עברית - Ministry of Health

אמלו 10

unipharm ltd, israel - amlodipine as maleate - טבליה - amlodipine as maleate 10 mg - amlodipine